Brilliance Candida 2 Agar and Spectra Candida Agar support earlier detection, faster outbreak response and more informed treatment decisions in healthcare settings*
TacroType™ Pharmacogenetic Test designed to support more personalized tacrolimus dosing, assisting clinical decision-making in solid organ transplant recipients
Kit enables genomic, transcriptomic and proteomic analysis from a single sample to support cancer and disease research
Strategic data collaboration will allow pharmaceutical and biotech companies to connect real-world data with clinical research
The Invitrogen™ TaqMan™ Cells-to-CT™ HepatoExpress Kit lets researchers measure gene activity in liver cells without doing RNA purification, so they can go from sample to results in about 75 minutes, with only 10 minutes of hands-on work
Dr. Nathan Ledeboer highlights how new antimicrobial combos and accurate susceptibility testing are helping fight against AMR
Partnership will advance scientific instrumentation and accelerate laboratory performance
For fast, non-destructive at-line testing in pharmaceutical and industrial environments
Registry developed to advance real-world evidence in treatment outcomes
Thermo Fisher Scientific launches Registry to advance real-world evidence in neurodegenerative care
New and expanded facilities provide local expertise, advanced technologies and tailored support for biopharma innovators throughout the region
New state-of-the-art facility in Philadelphia provides integrated lab and collaboration space along with tailored guidance to help move advanced therapies from early research to clinical readiness
New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production with confidence
6,000-square-foot facility enables clinical and commercial process development support to help cell therapy developers transition from research-scale to commercialization
General purpose centrifuges with next-generation natural refrigerant cooling system
Dr. Richard Knight, medical director of transplant diagnostics at Thermo Fisher Scientific explores personalized, non‑invasive approaches designed to improve transplant success
New Multiplex qPCR Assay developed in collaboration with Coca-Cola Europacific Partners delivers faster, broader detection to help protect product quality and brand reputation
First-of-its-kind, automated system delivers increased sensitivity, specific identification of disease markers and improved laboratory workflow to support fast, confident diagnoses
New solution uses automated 3D metrology to increase productivity in fabrication environments
The EFOX system delivers highly sensitive, full-scan data that helps labs detect persistent compounds faster, with more confidence, and in compliance with tightening regulations
New SwiftArrayStudio analyzer and updated genotyping arrays deliver results in as little as 30 hours, enabling researchers to drive impactful, scalable genetic research
